FOXD3 and thyroid gland carcinoma: demonstrated that inhibition of FOXD3-AS1 suppressed the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating the TGF-β1/Smads signaling pathway (Chen et al., 2019).